SCHEMBL7878044

SCHEMBL7878044

Bc1ccc2ncc3c(c2c1)n(-c1ccc(N2CCC2)nc1C)c(=O)n3C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 11/20 0.43
PIK3CA P42336 8/20 0.43
PIK3CD O00329 5/20 0.43
PIK3CB P42338 5/20 0.43
PIK3CG P48736 5/20 0.43
ATM Q13315 13/20 0.41
ATR Q13535 6/20 0.40
PIK3C3 Q8NEB9 2/20 0.38
CSNK2A2 P19784 1/20 0.38
FECH P22830 1/20 0.38
CLK1 P49759 1/20 0.38
GSK3A P49840 1/20 0.38
DYRK1A Q13627 1/20 0.38
MELK Q14680 1/20 0.38
MYLK3 Q32MK0 1/20 0.38
PIP4K2C Q8TBX8 1/20 0.38
TP53RK Q96S44 1/20 0.38
PRKDC P78527 2/20 0.37
PIK3C2A O00443 2/20 0.36
PIK3C2B O00750 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7874775 0.98 MTOR (0.43) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL3512636 0.88 MTOR (0.43) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL7876955 0.86 ATM (0.44) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL7878799 0.86 ATM (0.44) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL3513970 0.86 MTOR (0.43) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL7870203 0.86 MTOR (0.47) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL7875289 0.84 MTOR (0.45) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL7878805 0.83 MTOR (0.47) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL2067390 0.83 ATM (0.51) MTORPIK3CAPIK3CDPIK3CBPIK3CG
SCHEMBL2068730 0.83 MTOR (0.51) MTORPIK3CAPIK3CDPIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010139747-A1 1H-IMIDAZO[4, 5-c]QUINOLINONE COMPOUNDS, USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES NOVARTIS AG (CH) 2010-12-09 WO disclosed